Organogenesis Holdings (ORGO) Share-based Compensation (2018 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Share-based Compensation of $3.6 million for Q1 2026, up 102.45% year-over-year from $1.8 million in Q1 2025, and up 151.29% quarter-over-quarter from -$7.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Share-based Compensation (2018 - 2026) Analysis & Trends
Organogenesis Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 102.45% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $1.4 million (down 87.21% YoY), while the FY2025 annual figure was $1.9 million, down 71.06% from the prior year.
- Share-based Compensation for Q1 2026 stood at $3.6 million, up from -$7.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $13.5 million in Q2 2025, with the low at -$7.1 million in Q4 2025.
- The 5-year median for Share-based Compensation is $1.9 million (2023), against an average of $2.1 million.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation surged 1019.3% in 2023, then slumped 280.11% in 2025.
- Organogenesis Holdings' Share-based Compensation stood at $702000.0 in 2022, then rose by 4.13% to $731000.0 in 2023, then jumped by 438.44% to $3.9 million in 2024, then plunged by 280.11% to -$7.1 million in 2025, then surged by 151.29% to $3.6 million in 2026.
- Business Quant data shows ORGO's Share-based Compensation at $3.6 million in Q1 2026, -$7.1 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 23.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.49 Mn |
| Jun 30, 2026 | 23.49 Mn |
| Mar 31, 2026 | 3.64 Mn |
| Mar 31, 2026 | 3.64 Mn |
| Dec 31, 2025 | -7.09 Mn |
| Dec 31, 2025 | -7.09 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 13.54 Mn |
| Jun 30, 2025 | 13.54 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 2.57 Mn |
| Mar 31, 2024 | 701,000.00 |
| Mar 31, 2024 | 701,000.00 |